$68.40 0.00 (%) Bristol-Myers Squibb Co - NYSE

May. 27, 2015 | 04:00 PM

Partner Headlines

  1. Fast Money Picks For May 27

    Benzinga | May. 26, 2015 | 20:58PM EST
  2. Merck got EU's CHMP

    IBD | May. 22, 2015 | 18:22PM EST
  3. Puma Crashes, Roche Rises On Cancer Data News

    IBD | May. 14, 2015 | 12:59PM EST
  4. Berenberg Initiates Bristol-Myers Squibb With Hold

    Benzinga | May. 14, 2015 | 09:30AM EST
  5. Benzinga's Top Initiations

    Benzinga | May. 14, 2015 | 09:19AM EST
  6. Benzinga's Top #PreMarket Losers

    Benzinga | May. 14, 2015 | 08:18AM EST
  7. Bristol-Myers Squibb to Present Data at 2015 American Society of Clinical Oncology from its Broad Immuno-Oncology Portfolio Across Solid Tumors (Last Night)

    Benzinga | May. 14, 2015 | 07:56AM EST
  8. Making Money With Charles Payne: 05/8/15

    FoxBusiness | May. 8, 2015 | 18:00PM EST
  9. Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio

    GuruFocus | May. 7, 2015 | 12:24PM EST
  10. Merck's Stock Price, Dividend Yield Beating S&P 500

    IBD | May. 6, 2015 | 18:13PM EST
  11. Bristol-Myers Squibb

    IBD | May. 5, 2015 | 18:49PM EST
  12. Vanguard Adds to Four of Its Largest Stakes

    GuruFocus | May. 4, 2015 | 19:24PM EST
  13. Merck Jumps, United Therapeutics Drops On Q1 Earnings

    IBD | Apr. 28, 2015 | 18:50PM EST
  14. Merck Up On Q1, Januvia Report; Bristol, Pfizer Mixed

    IBD | Apr. 28, 2015 | 12:47PM EST
  15. Stock Futures Mixed, Nasdaq Up; Apple, Vasco, Merck Rising

    IBD | Apr. 28, 2015 | 09:02AM EST
  16. Earnings Scheduled For April 28, 2015

    Benzinga | Apr. 28, 2015 | 04:35AM EST
  17. Nasdaq Leads Market Lower As Medical Stocks Tumble

    IBD | Apr. 27, 2015 | 16:16PM EST
  18. 4 Drug Giants Reporting Earnings This Week

    IBD | Apr. 27, 2015 | 13:33PM EST
  19. Benzinga's Weekend M&A Chatter

    Benzinga | Apr. 26, 2015 | 19:17PM EST
  20. U.S. Tech, Dollar & Health Care ETFs To Watch This Week

    Benzinga | Apr. 26, 2015 | 10:52AM EST
  21. Benzinga's Top Upgrades

    Benzinga | Apr. 21, 2015 | 12:35PM EST
  22. Cancer Drugs Impress Again

    IBD | Apr. 20, 2015 | 18:43PM EST
  23. CAR-T Therapy Stocks Hit Hard Following AACR Data

    Benzinga | Apr. 20, 2015 | 13:44PM EST
  24. Bristol, Merck Cancer Drugs Strut Their Stuff

    IBD | Apr. 20, 2015 | 11:29AM EST
  25. Bristol-Myers scores again

    IBD | Apr. 17, 2015 | 19:01PM EST
  26. It's A Big Weekend For Biotech

    Benzinga | Apr. 17, 2015 | 16:31PM EST
  27. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD | Apr. 17, 2015 | 16:14PM EST
  28. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD | Apr. 17, 2015 | 10:44AM EST
  29. Bristol-Myers Up Big After Drug Study Stopped Early

    Benzinga | Apr. 17, 2015 | 10:23AM EST
  30. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD | Apr. 14, 2015 | 14:37PM EST
  31. Benzinga's M&A Chatter for Monday April 13, 2015

    Benzinga | Apr. 13, 2015 | 17:48PM EST
  32. Bristol-Myers Squibb Canada Announces Hepatitis C Cure Rate of 97% in Study of Patients Co-infected with HIV Given 12-week Combination Treatment of Daclatasvir and Sofosbuvir in ALLY-2 Trial

    Benzinga | Mar. 3, 2015 | 06:22AM EST
  33. UPDATE: USDA Approves Supplimental Biologics License

    Benzinga | Mar. 2, 2015 | 09:28AM EST
  34. USDA Accepts Supplemental Biologics License Application for Yervoy As Adjuvant Treatment for Patients with Stage 3 Melanoma Who Are at High Risk of Recurrence

    Benzinga | Mar. 2, 2015 | 09:27AM EST
  35. Bristol Myers Reports Data Supporting Clinical Development Of BMS-955176

    Benzinga | Feb. 26, 2015 | 08:35AM EST
  36. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  37. Bristol-Myers Squibb Launches Phase III Trial Of HIV Drug

    Benzinga | Feb. 25, 2015 | 12:57PM EST
  38. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD | Feb. 24, 2015 | 15:58PM EST
  39. Bristol-Myers goes for the gut

    IBD | Feb. 23, 2015 | 18:33PM EST
  40. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  41. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  42. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  43. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST
  44. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga | Feb. 23, 2015 | 07:34AM EST
  45. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices

    Benzinga | Feb. 20, 2015 | 13:10PM EST
  46. Strong Dollar Weakens Views

    IBD | Jan. 27, 2015 | 18:48PM EST
  47. Drugmakers Warn On Dollar

    IBD | Jan. 27, 2015 | 18:47PM EST
  48. Strong Dollar Pins U.S. Corporate Earnings Outlook

    IBD | Jan. 27, 2015 | 18:29PM EST
  49. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD | Jan. 27, 2015 | 18:10PM EST
  50. Strong Dollar Means Flabby Outlook For Some Overseas

    IBD | Jan. 27, 2015 | 13:45PM EST
Trading Center